DE3856367D1 - Verfahren zur Messung von Gewebeplasminogenaktivator, Antithrombin-III und lösliches Fibrin - Google Patents

Verfahren zur Messung von Gewebeplasminogenaktivator, Antithrombin-III und lösliches Fibrin

Info

Publication number
DE3856367D1
DE3856367D1 DE3856367T DE3856367T DE3856367D1 DE 3856367 D1 DE3856367 D1 DE 3856367D1 DE 3856367 T DE3856367 T DE 3856367T DE 3856367 T DE3856367 T DE 3856367T DE 3856367 D1 DE3856367 D1 DE 3856367D1
Authority
DE
Germany
Prior art keywords
plasminogen activator
tissue plasminogen
antithrombin iii
measuring tissue
soluble fibrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3856367T
Other languages
English (en)
Other versions
DE3856367T2 (de
Inventor
Mats Gustaf Ranby
Tor-Bjorn Wiman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biopool International Inc
Original Assignee
Biopool International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopool International Inc filed Critical Biopool International Inc
Application granted granted Critical
Publication of DE3856367D1 publication Critical patent/DE3856367D1/de
Publication of DE3856367T2 publication Critical patent/DE3856367T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8132—Plasminogen activator inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/968—Plasmin, i.e. fibrinolysin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator
DE3856367T 1987-07-06 1988-07-05 Verfahren zur Messung von Gewebeplasminogenaktivator, Antithrombin-III und lösliches Fibrin Expired - Fee Related DE3856367T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7006887A 1987-07-06 1987-07-06

Publications (2)

Publication Number Publication Date
DE3856367D1 true DE3856367D1 (de) 1999-11-11
DE3856367T2 DE3856367T2 (de) 2000-05-11

Family

ID=22092923

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3856367T Expired - Fee Related DE3856367T2 (de) 1987-07-06 1988-07-05 Verfahren zur Messung von Gewebeplasminogenaktivator, Antithrombin-III und lösliches Fibrin

Country Status (7)

Country Link
EP (2) EP0324027A4 (de)
JP (1) JP2710376B2 (de)
AT (1) ATE185376T1 (de)
AU (1) AU2314688A (de)
CA (1) CA1324748C (de)
DE (1) DE3856367T2 (de)
WO (1) WO1989000005A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633366B2 (en) * 1989-10-02 1993-01-28 Teijin Limited Human tissue plasminogen activator-human plasminogen activator inhibitor complex immunoassay and kit therefor
AU644205B2 (en) * 1990-08-23 1993-12-02 New York Blood Center, Inc., The Assays using a soluble fibrin-like monomer
SE9201615L (sv) * 1992-05-21 1993-11-22 Chromogenix Ab Bioimmunologisk metod för bestämning av tPa och PAI-1
AU7384494A (en) * 1993-06-28 1995-01-24 Akzo Nobel N.V. Quantification of active plasminogen-activator-inhibitor-type-1
US5843608A (en) * 1995-06-08 1998-12-01 Coulter International Corp. Reagent and method for differential determination of leukocytes in blood
US5762255A (en) * 1996-02-20 1998-06-09 Richard-Allan Medical Industries, Inc. Surgical instrument with improvement safety lockout mechanisms
CA2307954C (en) 1997-04-03 2010-07-13 California Institute Of Technology Enzyme-medicated modification of fibrin for tissue engineering
FR2813395B1 (fr) 2000-08-28 2003-01-24 Stago Diagnostica Methode de dosage in vitro de la fibrine soluble par generation de produits de degradation specifiques
US7473548B2 (en) 2003-04-25 2009-01-06 Medtronic, Inc. Optical detector for enzyme activation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8201987A (nl) * 1982-05-13 1983-12-01 Tno Werkwijze voor het bepalen van de activiteit van plasminogeenactivator van het weefseltype, alsmede voor gebruik bij deze werkwijze geschikte combinatie van het "kit"-type.
DE3430906A1 (de) * 1984-08-22 1986-02-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung von fibrinmonomer in plasma
SE447579B (sv) * 1985-04-01 1986-11-24 Biopool Ab Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar

Also Published As

Publication number Publication date
ATE185376T1 (de) 1999-10-15
JP2710376B2 (ja) 1998-02-10
EP0324027A1 (de) 1989-07-19
EP0576038A3 (en) 1994-06-08
CA1324748C (en) 1993-11-30
DE3856367T2 (de) 2000-05-11
EP0576038B1 (de) 1999-10-06
EP0324027A4 (en) 1990-10-10
AU2314688A (en) 1989-01-30
EP0576038A2 (de) 1993-12-29
WO1989000005A1 (en) 1989-01-12
JPH02500805A (ja) 1990-03-22

Similar Documents

Publication Publication Date Title
DE3874798T2 (de) Therapeutisches proteinagens in form von aerosol.
DE69018910T2 (de) Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren.
NO851225L (no) Sammensetning og forsoeksinnretning til bestemmelse av tilstedevaerelsen av leukocytter, esterase og protease i en proeve
DE3680271D1 (de) Thrombolytische zusammensetzung und verfahren zu deren herstellung.
DE3788762T2 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
DE3856367D1 (de) Verfahren zur Messung von Gewebeplasminogenaktivator, Antithrombin-III und lösliches Fibrin
ATE17262T1 (de) Verfahren zur quantitativen bestimmung von blutgerinnungsfaktor xii in humanplasma.
ATE45771T1 (de) Verfahren zur bestimmung des fibrinolytischen zustands von plasma.
ATE40718T1 (de) Verfahren zur bestimmung von fibrinmonomer in plasma.
ATE20780T1 (de) Methode zur fruehbestimmung der schwangerschaft.
DK226889A (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
DE69124030D1 (de) Testverfahren, die ein lösliches fibrinähnliches Monomer nutzen
KR900700443A (ko) 머캅토-아실아미노산 항고혈압제
ATA99992A (de) Verfahren zur bestimmung von fibrinogen
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
DE69302719T2 (de) Kalibrator und Verwendung davon in einer Immuntest
ATE119578T1 (de) Verfahren und reagenz zur bestimmung von antithrombin iii.
ATE115188T1 (de) Antikörper gegen fibrin, immunogen zur herstellung desselben, verfahren zur bestimmung von fibrin und pharmazeutisches präparat auf basis der antikörper.
ATE85365T1 (de) Verfahren zur bestimmung von protein c-inhibitor.
FI830293A0 (fi) Foerfarande foer bestaemning av allergisk kaenslighet
SE8303020D0 (sv) Bestemning av losligt fibrin med tillempning i blodplasma

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee